Susan Erickson‐Viitanen
Incyte (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Myeloproliferative Neoplasms: Diagnosis and Treatment, Click Chemistry and Applications, Biochemical and Molecular Research
Most-Cited Works
- → A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis(2012)2,014 cited
- → Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis(2010)1,159 cited
- → Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease Inhibitors(1994)835 cited
- → Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors(2000)300 cited
- → p-Benzoyl-L-phenylalanine, a new photoreactive amino acid. Photolabeling of calmodulin with a synthetic calmodulin-binding peptide.(1986)228 cited
- → Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial(2013)190 cited